These lipid improvements translate to reduced calculated cardiovascular risk scores and potentially lower long-term cardiovascular event rates
Even among the 5.5% of patients in the semaglutide group who actually gained weight , there appeared to be some cardiovascular benefit, though the effect was less pronouncedpossibly due to medication non-adherence
These changes help with weight management and lead to a mean weight loss of 15% after 68 weeks
After a month, the patient reported that she had taken semaglutide 7 mg BD for 5 days alternating with 14 mg BD for the next 5 days in the previous 2 weeks
21 Thereafter, it regulates learning, memory, 22 and neuron survival
This makes it difficult for the body to digest these nutrients properly, which can lead to diarrhea